Intranasal Third-Generation CGRP Effective for Acute Migraine Intranasal Third-Generation CGRP Effective for Acute Migraine

Intranasal zavegepant, a third-generation calcitonin gene-related peptide receptor agonist, is effective and well tolerated in the treatment of acute migraine, new research shows.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news